Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Radzikowska (Warsaw, Poland), E. Wiatr (Warsaw, Poland), K. Blasinska-Przerwa (Warsaw, Poland), M. Jeskiewicz (Warsaw, Poland), R. Langfort (Warsaw, Poland), B. Maksymiuk (Warsaw, Poland), K. Modrzewska (Warsaw, Poland), I. Bestry (Warsaw, Poland), M. Zaleska (Warsaw, Poland), J. Szopinski (Warsaw, Poland), A. Jerzemska (Bydgoszcz, Poland), M. Ochman (Zabrze, Poland), W. Naumnik (Bialystok, Poland), D. Jastrzebski (Zabrze, Poland), W. Piotrowski (Lódz, Poland), K. Roszkowski-Sliz (Warsaw, Poland). Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis. 3683

Member's Comments

No comment yet.

Related content which might interest you: Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy Source: Eur Respir J 2001; 18: Suppl. 33, 219s Year: 2001 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Effectiveness of chemotherapy treatment for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006